| Year |
Citation |
Score |
| 2020 |
Subbiah V, Cote GJ. Advances in Targeting RET-Dependent Cancers. Cancer Discovery. PMID 32094155 DOI: 10.1158/2159-8290.Cd-19-1116 |
0.33 |
|
| 2019 |
Maxwell JE, Gule-Monroe MK, Subbiah V, Hu M, Perrier ND, Cabanillas ME, Lee JE, Graham PH, Cote GJ, Busaidy NL, Grubbs EG. Novel use of a CLIA-certified CDKN2C loss assay in sporadic medullary thyroid carcinoma. Surgery. PMID 31648931 DOI: 10.1016/J.Surg.2019.03.041 |
0.32 |
|
| 2019 |
Hurst Z, Liyanarachchi S, He H, Brock P, Sipos JA, Nabhan F, Kebebew E, Green P, Cote GJ, Sherman SI, Walker CJ, Chang YS, Xue S, Hollingsworth B, Li W, et al. Risk Haplotypes Uniquely Associated with Radioiodine Refractory Thyroid Cancer Patients of High African Ancestry. Thyroid : Official Journal of the American Thyroid Association. PMID 30654714 DOI: 10.1089/Thy.2018.0687 |
0.309 |
|
| 2018 |
Bagheri-Yarmand R, Sinha KM, Li L, Lu Y, Cote GJ, Sherman SI, Gagel RF. Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer. Molecular Cancer Research : McR. PMID 30552230 DOI: 10.1158/1541-7786.Mcr-18-0354 |
0.38 |
|
| 2018 |
Puli OR, Danysh BP, McBeath E, Sinha DK, Hoang NM, Powell RT, Danysh HE, Cabanillas ME, Cote GJ, Hofmann MC. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells. Neoplasia (New York, N.Y.). 20: 1121-1134. PMID 30265861 DOI: 10.1016/J.Neo.2018.09.003 |
0.461 |
|
| 2018 |
Valenciaga A, Saji M, Yu L, Zhang X, Bumrah C, Yilmaz AS, Knippler CM, Miles W, Giordano TJ, Cote GJ, Ringel MD. Transcriptional targeting of oncogene addiction in medullary thyroid cancer. Jci Insight. 3. PMID 30135308 DOI: 10.1172/Jci.Insight.122225 |
0.418 |
|
| 2018 |
Jaber T, Hyde SM, Cote GJ, Grubbs EG, Giles WH, Stevens CA, Dadu R. A homozygous RET K666N genotype with an MEN2A phenotype. The Journal of Clinical Endocrinology and Metabolism. PMID 29408964 DOI: 10.1210/Jc.2017-02402 |
0.314 |
|
| 2018 |
Wang JR, Cote GJ, Zafereo M, Iyer PC, Dadu R, Busaidy NL, Gross ND, Sturgis EM, Ferrarotto R, Lu C, Gunn GB, Myers J, Lai SY, Williams MD, Cabanillas ME. Facilitating rapid precision oncology in anaplastic thyroid cancer: Clinical implications of next generation sequencing (NGS) mutation testing and impact on survival. Journal of Clinical Oncology. 36: 6023-6023. DOI: 10.1200/Jco.2018.36.15_Suppl.6023 |
0.319 |
|
| 2017 |
Christakis I, Qiu W, Hyde SM, Cote GJ, Grubbs EG, Perrier ND, Lee JE. Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution. Surgery. PMID 29122330 DOI: 10.1016/J.Surg.2017.04.044 |
0.306 |
|
| 2017 |
Valenciaga A, Grubbs EG, Porter K, Wakely PE, Williams MD, Cote GJ, Vasko VV, Saji M, Ringel MD. REDUCED RETINOBLASTOMA PROTEIN EXPRESSION IS ASSOCIATED WITH DECREASED PATIENT SURVIVAL IN MEDULLARY THYROID CANCER. Thyroid : Official Journal of the American Thyroid Association. PMID 29105562 DOI: 10.1089/Thy.2017.0113 |
0.423 |
|
| 2017 |
Cote GJ, Evers C, Hu MI, Grubbs EG, Williams MD, Hai T, Duose DY, Houston MR, Bui JH, Mehrotra M, Waguespack SG, Busaidy NL, Cabanillas ME, Habra MA, Luthra R, et al. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology and Metabolism. 102: 3591-3599. PMID 28911154 DOI: 10.1210/Jc.2017-01039 |
0.342 |
|
| 2017 |
Voss RK, Feng L, Lee JE, Perrier ND, Graham PH, Hyde SM, Nieves-Munoz F, Cabanillas ME, Waguespack SG, Cote GJ, Gagel RF, Grubbs EG. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate or High-Risk RET Mutations Do Not Predict Disease Aggressiveness The Journal of Clinical Endocrinology and Metabolism. PMID 28609830 DOI: 10.1210/Jc.2017-00317 |
0.308 |
|
| 2016 |
Sandulache VC, Williams MD, Lai SY, Lu C, William WN, Busaidy N, Cote GJ, Singh R, Luthra R, Cabanillas M. Real-time genomic characterization utilizing circulating cell-free DNA in patients with anaplastic thyroid carcinoma. Thyroid : Official Journal of the American Thyroid Association. PMID 27785980 DOI: 10.1089/Thy.2016.0076 |
0.334 |
|
| 2016 |
Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Vassilopoulou-Sellin R, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ. Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation. Thyroid : Official Journal of the American Thyroid Association. PMID 27673361 DOI: 10.1089/Thy.2016.0374 |
0.334 |
|
| 2016 |
Grubbs EG, Williams MD, Scheet P, Vattathil S, Perrier N, Lee JE, Gagel RF, Hai T, Feng L, Cabanillas M, Cote GJ. The role of CDKN2C copy number in sporadic medullary thyroid carcinoma. Thyroid : Official Journal of the American Thyroid Association. PMID 27610696 DOI: 10.1089/Thy.2016.0224 |
0.366 |
|
| 2016 |
Yu Xu J, Handy B, Michaelis CL, Waguespack SG, Hu MI, Busaidy N, Jimenez C, Cabanillas ME, Fritsche HA, Cote GJ, Sherman SI. Detection and Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Thyroid Cancer. The Journal of Clinical Endocrinology and Metabolism. jc20162567. PMID 27575943 DOI: 10.1210/Jc.2016-2567 |
0.358 |
|
| 2016 |
Georgescu MM, Gagea M, Cote G. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia. Neoplasia (New York, N.Y.). 18: 512-23. PMID 27566107 DOI: 10.1016/J.Neo.2016.07.003 |
0.34 |
|
| 2016 |
Christakis IA, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND. Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in MEN1 Patients; A Clinico-Pathologic Challenge. The MD Anderson Case Series and Review of the Literature. International Journal of Surgery (London, England). PMID 27212590 DOI: 10.1016/J.Ijsu.2016.05.035 |
0.315 |
|
| 2016 |
Danysh BP, Rieger EY, Sinha DK, Evers CV, Cote GJ, Cabanillas ME, Hofmann MC. Long-Term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model. Oncotarget. PMID 27127178 DOI: 10.18632/Oncotarget.9023 |
0.332 |
|
| 2016 |
Xu JY, Zaidi TM, Cote GJ, Hu MI, Waguespack SG, Cabanillas ME, Ying AK, Busaidy NL, Habra MA, Shanbhag N, Truong D, Yu RK, Shete S, Katz RL, Sherman SI. Accurate detection of circulating tumor cells (CTCs) in patients with metastatic papillary thyroid cancer (MPTC) via an interphase fluorescence in situ hybridization (IFISH) assay. Journal of Clinical Oncology. 34: e17550-e17550. DOI: 10.1200/Jco.2016.34.15_Suppl.E17550 |
0.311 |
|
| 2016 |
Xu JY, Handy BC, Waguespack SG, Hu MI, Busaidy NL, Jimenez C, Cabanillas ME, Cote GJ, Sherman SI. Effect of circulating tumor cells (CTCs) on overall survival in metastatic medullary thyroid cancer (metMTC). Journal of Clinical Oncology. 34: e17547-e17547. DOI: 10.1200/Jco.2016.34.15_Suppl.E17547 |
0.312 |
|
| 2016 |
Bagheri-Yarmand R, Cote GJ, Grubbs EG, Williams MD, Sherman SI, Gagel RF. Abstract 3660: ATF4 is a putative tumor suppressor gene in medullary thyroid cancer Cancer Research. 76: 3660-3660. DOI: 10.1158/1538-7445.Am2016-3660 |
0.425 |
|
| 2016 |
Evers C, Duose DY, Mehrotra M, Hai T, Houston MR, Hu PC, Luthra R, Sherman SI, Cote GJ. Liquid Biopsy: Comparison of Mutation Detection Methods for Measurement of RET M918T Circulating Cell-Free DNA in Medullary Thyroid Cancer Patients Cancer Genetics. 209: 287. DOI: 10.1016/J.Cancergen.2016.04.012 |
0.319 |
|
| 2015 |
Cote GJ, Grubbs EG, Hofmann MC. Thyroid C-Cell Biology and Oncogenic Transformation. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 204: 1-39. PMID 26494382 DOI: 10.1007/978-3-319-22542-5_1 |
0.389 |
|
| 2015 |
Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, et al. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Research. PMID 26282167 DOI: 10.1158/0008-5472.Can-14-3707 |
0.385 |
|
| 2015 |
Rich T, Jackson M, Roman-Gonzalez A, Shah K, Cote GJ, Jimenez C. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene. Familial Cancer. 14: 615-9. PMID 26162468 DOI: 10.1007/S10689-015-9821-0 |
0.383 |
|
| 2015 |
Pozo K, Hillmann A, Augustyn A, Plattner F, Hai T, Singh T, Ramezani S, Sun X, Pfragner R, Minna JD, Cote GJ, Chen H, Bibb JA, Nwariaku FE. Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis. Oncotarget. 6: 12080-93. PMID 25900242 DOI: 10.18632/Oncotarget.3813 |
0.426 |
|
| 2015 |
Bagheri-Yarmand R, Sinha KM, Gururaj AE, Ahmed Z, Rizvi YQ, Huang SC, Ladbury JE, Bogler O, Williams MD, Cote GJ, Gagel RF. A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis. The Journal of Biological Chemistry. 290: 11749-61. PMID 25795775 DOI: 10.1074/Jbc.M114.619833 |
0.383 |
|
| 2015 |
Grubbs EG, Ng PK, Bui J, Busaidy NL, Chen K, Lee JE, Lu X, Lu H, Meric-Bernstam F, Mills GB, Palmer G, Perrier ND, Scott KL, Shaw KR, Waguespack SG, ... ... Cote GJ, et al. RET fusion as a novel driver of medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 100: 788-93. PMID 25546157 DOI: 10.1210/Jc.2014-4153 |
0.35 |
|
| 2014 |
Cabanillas ME, Hu MI, Jimenez C, Grubbs EG, Cote GJ. Treating medullary thyroid cancer in the age of targeted therapy. International Journal of Endocrine Oncology. 1: 203-216. PMID 25908961 DOI: 10.2217/Ije.14.26 |
0.341 |
|
| 2014 |
Baudin E, Habra MA, Deschamps F, Cote G, Dumont F, Cabanillas M, Arfi-Roufe J, Berdelou A, Moon B, Al Ghuzlan A, Patel S, Leboulleux S, Jimenez C. Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. European Journal of Endocrinology / European Federation of Endocrine Societies. 171: R111-22. PMID 24891137 DOI: 10.1530/Eje-14-0113 |
0.323 |
|
| 2014 |
Georgescu MM, Cote G, Agarwal NK, White CL. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane. Neoplasia (New York, N.Y.). 16: 365-74.e1-2. PMID 24862762 DOI: 10.1016/J.Neo.2014.04.004 |
0.315 |
|
| 2014 |
Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib. The Journal of Clinical Endocrinology and Metabolism. 99: 2086-94. PMID 24628550 DOI: 10.1210/Jc.2013-3588 |
0.307 |
|
| 2014 |
Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying A, Grubbs E. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid : Official Journal of the American Thyroid Association. 24: 1096-106. PMID 24617864 DOI: 10.1089/Thy.2013.0620 |
0.304 |
|
| 2014 |
Agarwal NK, Zhu X, Gagea M, White CL, Cote G, Georgescu MM. PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase. Oncotarget. 5: 815-23. PMID 24553260 DOI: 10.18632/Oncotarget.1774 |
0.32 |
|
| 2014 |
Bagheri-Yarmand R, Cote GJ, Gagel RF. Abstract 5262: Activating transcription factor 4 regulates RET autophosphorylation and ubiquitin-dependent degradation Cancer Research. 74: 5262-5262. DOI: 10.1158/1538-7445.Am2014-5262 |
0.413 |
|
| 2014 |
Pozo K, Hillmann A, Augustyn A, Singh T, Plattner F, Minna J, Chen H, Cote GJ, Bibb JA, Nwariaku FE. Abstract 3923: Molecular characterization of an animal model for neuroendocrine thyroid cancer Cancer Research. 74: 3923-3923. DOI: 10.1158/1538-7445.Am2014-3923 |
0.417 |
|
| 2013 |
Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. The Journal of Clinical Endocrinology and Metabolism. 98: E1813-9. PMID 24030942 DOI: 10.1210/Jc.2013-1653 |
0.302 |
|
| 2013 |
Larsson CA, Cote G, Quintás-Cardama A. The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome Molecular Cancer Research. 11: 815-827. PMID 23645565 DOI: 10.1158/1541-7786.Mcr-12-0695 |
0.327 |
|
| 2012 |
Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, Li Y, Verma IM, Chiao PJ, Lu Z. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis. Molecular Cell. 48: 771-84. PMID 23123196 DOI: 10.1016/J.Molcel.2012.09.028 |
0.335 |
|
| 2012 |
Cote GJ, Zhu W, Thomas A, Martin E, Murad F, Sharina IG. Hydrogen Peroxide alters splicing of soluble Guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells Plos One. 7. PMID 22911749 DOI: 10.1371/Journal.Pone.0041099 |
0.336 |
|
| 2012 |
Izaguirre DI, Zhu W, Hai T, Cheung HC, Krahe R, Cote GJ. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis. Molecular Carcinogenesis. 51: 895-906. PMID 21976412 DOI: 10.1002/Mc.20859 |
0.773 |
|
| 2012 |
Molina JR, Agarwal NK, Morales FC, Hayashi Y, Aldape KD, Cote G, Georgescu MM. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene. 31: 1264-74. PMID 21804599 DOI: 10.1038/Onc.2011.324 |
0.351 |
|
| 2011 |
Sharina IG, Cote GJ, Martin E, Doursout MF, Murad F. RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase Nitric Oxide - Biology and Chemistry. 25: 265-274. PMID 21867767 DOI: 10.1016/J.Niox.2011.08.001 |
0.355 |
|
| 2011 |
Waguespack SG, Rich TA, Perrier ND, Jimenez C, Cote GJ. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nature Reviews. Endocrinology. 7: 596-607. PMID 21862994 DOI: 10.1038/Nrendo.2011.139 |
0.337 |
|
| 2011 |
Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. The Journal of Clinical Endocrinology and Metabolism. 96: 717-25. PMID 21190975 DOI: 10.1210/Jc.2010-1946 |
0.319 |
|
| 2011 |
Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid : Official Journal of the American Thyroid Association. 21: 189-92. PMID 21186952 DOI: 10.1089/Thy.2010.0328 |
0.303 |
|
| 2011 |
Wang L, Liu Z, Balivada S, Pyle M, Cote GJ, Shi J, Troyer D. Abstract LB-98: Reprogramming towards glioma stem-like cells by cytokines Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-98 |
0.32 |
|
| 2010 |
Zhu W, Hai T, Ye L, Cote GJ. Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity. The Journal of Clinical Endocrinology and Metabolism. 95: 439-44. PMID 19897677 DOI: 10.1210/Jc.2009-1485 |
0.36 |
|
| 2009 |
Hu J, He X, Cote GJ, Krahe R. Singular Value Decomposition-based Alternative Splicing Detection. Journal of the American Statistical Association. 104: 944-953. PMID 20305737 DOI: 10.1198/Jasa.2009.Ap08283 |
0.324 |
|
| 2009 |
Cheung HC, Hai T, Zhu W, Baggerly KA, Tsavachidis S, Krahe R, Cote GJ. Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain : a Journal of Neurology. 132: 2277-88. PMID 19506066 DOI: 10.1093/Brain/Awp153 |
0.768 |
|
| 2008 |
Habra MA, Jimenez C, Huang SC, Cote GJ, Murphy WA, Gagel RF, Hoff AO. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 14: 1108-14. PMID 19158050 DOI: 10.4158/Ep.14.9.1108 |
0.31 |
|
| 2008 |
Ye L, Santarpia L, Cote GJ, El-Naggar AK, Gagel RF. High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 93: 4367-72. PMID 18765511 DOI: 10.1210/Jc.2008-0912 |
0.33 |
|
| 2008 |
Cheung HC, Baggerly KA, Tsavachidis S, Bachinski LL, Neubauer VL, Nixon TJ, Aldape KD, Cote GJ, Krahe R. Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. Bmc Genomics. 9: 216. PMID 18474104 DOI: 10.1186/1471-2164-9-216 |
0.755 |
|
| 2008 |
Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. The Journal of Clinical Endocrinology and Metabolism. 93: 278-84. PMID 17989125 DOI: 10.1210/Jc.2007-1076 |
0.305 |
|
| 2007 |
Evans DB, Rich TA, Cote GJ. Surgical management of familial hyperparathyroidism. Annals of Surgical Oncology. 14: 1525-7. PMID 17285397 DOI: 10.1245/S10434-006-9282-7 |
0.368 |
|
| 2007 |
Evans DB, Shapiro SE, Cote GJ. Invited commentary: medullary thyroid cancer: the importance of RET testing. Surgery. 141: 96-9. PMID 17188173 DOI: 10.1016/J.Surg.2006.08.016 |
0.348 |
|
| 2006 |
Jiménez C, Cote G, Arnold A, Gagel RF. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? The Journal of Clinical Endocrinology and Metabolism. 91: 2851-8. PMID 16735498 DOI: 10.1210/Jc.2005-2178 |
0.321 |
|
| 2006 |
Cheung HC, Corley LJ, Fuller GN, McCutcheon IE, Cote GJ. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 1034-41. PMID 16729017 DOI: 10.1038/Modpathol.3800635 |
0.754 |
|
| 2006 |
Gagel RF, Shefelbine S, Hayashi H, Cote G. Multiple Endocrine Neoplasia Type 2 Archives of Surgery. 138: 393-399. DOI: 10.1007/978-1-59259-963-9_40 |
0.339 |
|
| 2005 |
Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, Sherman SI, Lee JE, Evans DB. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid : Official Journal of the American Thyroid Association. 15: 531-44. PMID 16029119 DOI: 10.1089/Thy.2005.15.531 |
0.349 |
|
| 2004 |
Jin W, Cote GJ. Enhancer-dependent splicing of FGFR1 alpha-exon is repressed by RNA interference-mediated down-regulation of SRp55. Cancer Research. 64: 8901-5. PMID 15604250 DOI: 10.1158/0008-5472.Can-04-0716 |
0.431 |
|
| 2004 |
Bruno IG, Jin W, Cote GJ. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements. Human Molecular Genetics. 13: 2409-20. PMID 15333583 DOI: 10.1093/Hmg/Ddh272 |
0.762 |
|
| 2004 |
Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. The Journal of Clinical Endocrinology and Metabolism. 89: 4142-5. PMID 15292360 DOI: 10.1210/Jc.2004-0041 |
0.337 |
|
| 2004 |
Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 89: 3521-6. PMID 15240641 DOI: 10.1210/Jc.2004-0073 |
0.351 |
|
| 2004 |
McCutcheon IE, Hentschel SJ, Fuller GN, Jin W, Cote GJ. Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain. Neuro-Oncology. 6: 9-14. PMID 14769134 DOI: 10.1215/S1152851703000279 |
0.389 |
|
| 2004 |
Bruno IG, Jin W, Cote GJ. Erratum: Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements (Human Molecular Genetics (2004) vol. 13 (2409-2420)) Human Molecular Genetics. 13. DOI: 10.1093/Hmg/Ddh297 |
0.333 |
|
| 2003 |
Jin W, Bruno IG, Xie TX, Sanger LJ, Cote GJ. Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion. Cancer Research. 63: 6154-7. PMID 14559795 |
0.753 |
|
| 2003 |
Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB, Yeston N, Kinder B, Deckers PJ. Multiple endocrine neoplasia type 2: Evaluation of the genotype-phenotype relationship Archives of Surgery. 138: 409-416. PMID 12686527 DOI: 10.1001/Archsurg.138.4.409 |
0.327 |
|
| 2002 |
Kikumori T, Cote GJ, Gagel RF. Naturally occurring heterologous trans-splicing of adenovirus RNA with host cellular transcripts during infection. Febs Letters. 522: 41-6. PMID 12095616 DOI: 10.1016/S0014-5793(02)02878-8 |
0.335 |
|
| 2002 |
Kouvaraki MA, Lee JE, Shapiro SE, Gagel RF, Sherman SI, Sellin RV, Cote GJ, Evans DB. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Archives of Surgery (Chicago, Ill. : 1960). 137: 641-7. PMID 12049533 DOI: 10.1001/Archsurg.137.6.641 |
0.346 |
|
| 2001 |
Thomas PM, Nasonkin I, Zhang H, Gagel RF, Cote GJ. Structure of the mouse calcitonin/calcitonin gene-related peptide alpha and beta genes. Dna Sequence : the Journal of Dna Sequencing and Mapping. 12: 131-5. PMID 11761712 DOI: 10.3109/10425170109047567 |
0.308 |
|
| 2001 |
Kikumori T, Cote GJ, Gagel RF. Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy? Human Gene Therapy. 12: 1429-41. PMID 11485634 DOI: 10.1089/104303401750298580 |
0.414 |
|
| 2000 |
Hoff AO, Cote GJ, Gagel RF. Multiple endocrine neoplasias. Annual Review of Physiology. 62: 377-411. PMID 10845096 DOI: 10.1146/Annurev.Physiol.62.1.377 |
0.318 |
|
| 1999 |
Hoff AO, Cote GJ, Fritsche HA, Qiu H, Schultz PN, Gagel RF. Calcium-Induced Activation of a Mutant G-Protein-Coupled Receptor Causes In Vitro Transformation of NIH/3T3 Cells Neoplasia. 1: 485-491. PMID 10935495 DOI: 10.1038/Sj.Neo.7900072 |
0.312 |
|
| 1999 |
Jin W, Huang ES, Bi W, Cote GJ. Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells. The Journal of Biological Chemistry. 274: 28035-41. PMID 10488155 DOI: 10.1074/Jbc.274.39.28035 |
0.39 |
|
| 1999 |
Otonkoski T, Ammälä C, Huopio H, Cote GJ, Chapman J, Cosgrove K, Ashfield R, Huang E, Komulainen J, Ashcroft FM, Dunne MJ, Kere J, Thomas PM. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes. 48: 408-15. PMID 10334322 DOI: 10.2337/Diabetes.48.2.408 |
0.322 |
|
| 1999 |
Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF. The surgical treatment of medullary thyroid carcinoma. Seminars in Surgical Oncology. 16: 50-63. PMID 9890740 DOI: 10.1002/(Sici)1098-2388(199901/02)16:1<50::Aid-Ssu9>3.0.Co;2-6 |
0.335 |
|
| 1998 |
Jin W, Huang ESC, Bi W, Cote GJ. Exon sequence is required for regulated RNA splicing of the human fibroblast growth factor receptor-1 α-exon Journal of Biological Chemistry. 273: 16170-16176. PMID 9632672 DOI: 10.1074/Jbc.273.26.16170 |
0.39 |
|
| 1998 |
Shefelbine SE, Khorana S, Schultz PN, Huang E, Thobe N, Hu ZJ, Fox GM, Jing S, Cote GJ, Gagel RF. Mutational analysis of the GDNF/RET-GDNFR alpha signaling complex in a kindred with vesicoureteral reflux. Human Genetics. 102: 474-8. PMID 9600247 DOI: 10.1007/S004390050724 |
0.384 |
|
| 1997 |
Cote GJ, Huang ESC, Jin W, Morrison RS. Sequence Requirements for Regulated RNA Splicing of the Human Fibroblast Growth Factor Receptor-1 α Exon Journal of Biological Chemistry. 272: 1054-1060. PMID 8995402 DOI: 10.1074/Jbc.272.2.1054 |
0.405 |
|
| 1997 |
Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocrinology and Metabolism Clinics of North America. 25: 1-25. PMID 8907678 DOI: 10.1016/S0889-8529(05)70310-8 |
0.308 |
|
| 1996 |
Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, Ploos Van Amstel HK, Lips CJM, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, et al. The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis Journal of the American Medical Association. 276: 1575-1579. PMID 8918855 DOI: 10.1001/Jama.276.19.1575 |
0.328 |
|
| 1996 |
Lou H, Yang Y, Cote GJ, Berget SM, Gagel RF. An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Molecular and Cellular Biology. 15: 7135-42. PMID 8524281 DOI: 10.1128/Mcb.15.12.7135 |
0.328 |
|
| 1995 |
Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science (New York, N.Y.). 268: 426-9. PMID 7716548 DOI: 10.1126/Science.7716548 |
0.338 |
|
| 1995 |
Gagel RF, Cote GJ, Martins Bugalho MJG, Boyd AE, Cummings T, Goepfert H, Evans DB, Cangir A, Khorana S, Schultz PN. Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A Journal of Internal Medicine. 238: 333-341. PMID 7595169 DOI: 10.1111/J.1365-2796.1995.Tb01207.X |
0.303 |
|
| 1995 |
Cote GJ, Wohllk N, Evans D, Goepfert H, Gagel RF. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Bailliere's Clinical Endocrinology and Metabolism. 9: 609-30. PMID 7575334 DOI: 10.1016/S0950-351X(95)80638-5 |
0.344 |
|
| 1995 |
Lou H, Cote GJ, Gagel RF. The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing. Molecular Endocrinology (Baltimore, Md.). 8: 1618-26. PMID 7535892 DOI: 10.1210/Mend.8.12.7535892 |
0.342 |
|
| 1992 |
Cote GJ, Stolow DT, Peleg S, Berget SM, Gagel RF. Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP. Nucleic Acids Research. 20: 2361-6. PMID 1594453 DOI: 10.1093/Nar/20.9.2361 |
0.394 |
|
| 1991 |
Peleg S, Abruzzese RV, Cote GJ, Gagel RF. Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements. Molecular Endocrinology (Baltimore, Md.). 4: 1750-7. PMID 2280775 DOI: 10.1210/Mend-4-11-1750 |
0.368 |
|
| 1991 |
Cote GJ, Nguyen IN, Berget SM, Gagel RF. Calcitonin exon sequences influence alternative RNA processing. Molecular Endocrinology (Baltimore, Md.). 4: 1744-9. PMID 2280774 DOI: 10.1210/Mend-4-11-1744 |
0.324 |
|
| 1991 |
Cote GJ, Nguyen IN, Lips CJ, Berget SM, Gagel RF. Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA. Nucleic Acids Research. 19: 3601-6. PMID 1649451 DOI: 10.1093/Nar/19.13.3601 |
0.35 |
|
| 1989 |
Rogers DG, Cote GJ, Huang ES, Gagel RF. 1,25-Dihydroxyvitamin D3 silences 3',5'-cyclic adenosine monophosphate enhancement of somatostatin gene transcription in human thyroid C cells. Molecular Endocrinology (Baltimore, Md.). 3: 547-51. PMID 2568585 DOI: 10.1210/Mend-3-3-547 |
0.304 |
|
| 1988 |
Cote GJ, Rogers DG, Huang ES, Gagel RF. The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells. Biochemical and Biophysical Research Communications. 149: 239-43. PMID 3500723 DOI: 10.1016/0006-291X(87)91630-5 |
0.338 |
|
| 1987 |
Cote GJ, Gould JA, Huang SCE, Gagel RF. Studies of short-term secretion of peptides produced by alternative RNA processing Molecular and Cellular Endocrinology. 53: 211-219. PMID 2822513 DOI: 10.1016/0303-7207(87)90176-6 |
0.332 |
|
| 1987 |
Wang Z, Cote GJ, Chiu JF. A specific alpha-fetoprotein gene binding protein in alpha-fetoprotein producing rat hepatomas. Biochemical and Biophysical Research Communications. 143: 110-5. PMID 2435286 DOI: 10.1016/0006-291X(87)90637-1 |
0.339 |
|
| Show low-probability matches. |